Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 20% within the next six months [19]. Core Viewpoints - The launch of new regenerative products positions the company as the only compliant holder of dual regenerative injectables in China [2]. - The company is transitioning from single product offerings to comprehensive aesthetic treatment solutions, addressing the evolving demands in the aesthetic medicine market [4]. - The company has established a robust product pipeline and distribution network, with over 60 products developed and a presence in more than 6,200 aesthetic institutions across 370 cities [5]. - The traditional pharmaceutical business is stabilizing, with a focus on innovative drugs, including the upcoming launches of key products [6]. Financial Performance and Forecast - Revenue projections for 2025-2027 are adjusted to 2.32 billion, 3.44 billion, and 4.73 billion RMB, respectively, with growth rates of 22%, 48%, and 37% [6]. - The net profit forecast for the same period is 63 million, 528 million, and 783 million RMB, with corresponding growth rates of 129%, 736%, and 48% [6]. - The expected price-to-earnings ratio for 2026 is 22 times, reflecting a positive outlook on profitability [6].

Investment Rating - The industry investment rating is maintained at "Outperform the Market" [1] Core Insights - The analysis indicates a continuous recovery in the heavy positions of pharmaceutical funds, with innovative drugs being the most recognized direction for increased investment [1][8] - In Q2 2025, the overall heavy position of pharmaceutical funds increased, with public funds' pharmaceutical heavy position at 9.8%, up by 0.7 percentage points from the previous quarter [3][13] - The total scale of pharmaceutical funds reached 338.5 billion yuan, reflecting a 3.7% increase quarter-on-quarter [24] Fund Holdings Overview - In Q2 2025, the heavy position of all public funds in the pharmaceutical sector rose, with active funds showing a heavier allocation compared to non-pharmaceutical funds [3][13] - The heavy position of pharmaceutical active funds accounted for 32% of the total heavy position market value in the pharmaceutical sector, while non-pharmaceutical active funds accounted for 34% [17][24] - The total number of pharmaceutical fund shares was 610.6 billion, down by 3.8% from the previous quarter [24] Sector Breakdown - The overall holding ratios for different sectors in the pharmaceutical industry showed varied changes, with Pharma, Bio-Tech, and Bio-Pharma seeing increases, while CXO and specialized chains experienced declines [7][10] - The holding ratio for Pharma increased by 0.39 percentage points, while Bio-Tech saw an increase of 0.21 percentage points [7][32] - The top three sectors with increased holdings in public funds were Bio-Pharma, Pharma, and Bio-Tech, while CXO, specialized chains, and medical devices saw the largest declines [10][36] Heavy Stock Analysis - The top five stocks by total market value held by all public funds in the pharmaceutical sector were: Heng Rui Medicine (32.1 billion), WuXi AppTec (24.7 billion), Mindray Medical (22.7 billion), Innovent Biologics (15.5 billion), and United Imaging Healthcare (11.9 billion) [10] - The active increase in market value for stocks included Innovent Biologics (+7 billion), Sanofi Biopharma (+6 billion), and Xinli Tai (+3 billion) [10] - The active reduction in market value was led by Aier Eye Hospital (-4.3 billion), WuXi AppTec (-4.2 billion), and Heng Rui Medicine (-2.5 billion) [10]

Investment Rating - The report gives a "Hold" rating for the company, QiXin Group [4][79]. Core Viewpoints - QiXin Group is a leading enterprise in domestic office procurement, transitioning from stationery manufacturing to a comprehensive office solution provider, focusing on digital procurement services for medium to large government and enterprise clients [2][11]. - The company is expected to benefit from the continuous penetration and market share increase in the B2B office procurement sector, as well as the expansion of its MRO (Maintenance, Repair, and Operations) business, which has significant growth potential [4][79]. - The report highlights the company's efforts in enhancing its self-owned brand through collaborations with popular domestic IPs, which is anticipated to improve its profit structure and create new growth points [4][66]. Summary by Sections Company Overview - QiXin Group, established in 1991, has evolved into a comprehensive procurement service platform, serving over 60 central enterprises and becoming a pioneer in the B2B procurement market [2][11]. Office Procurement - The digitalization of B2B office procurement is on the rise, with a projected market size of 175.4 trillion yuan in 2023, and a digital procurement penetration rate of approximately 9.8% [3][33]. - The company has developed a digital operation platform that covers various procurement needs, significantly reducing management costs for clients [3][53]. MRO Business - The MRO market is substantially larger than traditional office supplies, with an estimated size of 8.9 trillion yuan compared to 2 trillion yuan for traditional office supplies [3][36]. - QiXin Group's MRO business has already served major clients like State Grid and Southern Power Grid, positioning it for future growth [3][4]. Brand Development - The company has been enhancing its self-owned brand "COMIX QiXin" through IP collaborations, aiming to increase the proportion of high-value products [4][66]. - The domestic market for cultural and creative products is expected to grow significantly, with the company focusing on appealing to younger consumers [4][62]. Financial Forecast and Investment Suggestions - Revenue growth is projected at 11%, 9%, and 8% for 2025-2027, with net profit growth of 70%, 41%, and 37% respectively [4][75]. - The report anticipates an EPS of 0.15 yuan, 0.21 yuan, and 0.29 yuan for the same period, with a current PE ratio of 48x for 2025 [4][79].

Group 1 - The report emphasizes that 2025 will be a significant year for small nucleic acid drug investments due to three major industry trends: the maturity of the GalNac delivery platform, the expansion of indications from rare diseases to common diseases, and the intensification of commercialization and clinical data catalysts for small nucleic acid drugs [2][12][27] - The GalNac delivery technology has matured, allowing for effective liver-targeting with lower toxicity compared to previous systems like LNP, which had issues with immune reactions and production complexity [2][21][38] - Small nucleic acid drugs are transitioning from treating rare diseases to addressing more prevalent conditions such as hyperlipidemia and hypertension, significantly expanding the potential patient population and market opportunities [2][12][27] Group 2 - Key catalysts for small nucleic acid drugs include the expected commercial launch of Novartis' Inclisiran, which is projected to accelerate sales, and the anticipated approvals of several products like Alnylam's Vutrisiran and Fitusiran [2][27][30] - The report highlights the strong stock performance of small nucleic acid companies in the U.S. market, with Alnylam, Arrowhead, and Ionis seeing significant price increases of 39.6%, 63.9%, and 59.9% respectively from their April lows to July 18 [12][9] - The report suggests focusing on domestic companies such as Heng Rui Medicine, Zhengda Tianqing, and Xinlitai, as well as international firms like Alnylam and Ionis, which are leading in the small nucleic acid space [2][46][37] Group 3 - The report identifies the GalNac platform as a key value driver, with products beginning to demonstrate their market potential, particularly in liver-targeting applications [21][22] - Alnylam is recognized as a leader in the small nucleic acid field, having successfully commercialized multiple siRNA drugs and demonstrating a high clinical success rate of 62%, significantly above the industry average [38][12] - The report notes that major pharmaceutical companies are increasingly interested in small nucleic acid technologies, indicating a strong potential for partnerships and licensing agreements in this area [37][46]

Quantitative Models and Construction Methods 1. Model Name: "Core + Satellite" Dual-Layer Framework - **Model Construction Idea**: The model aims to balance "stability" and "growth" by combining low-correlation asset classes to smooth volatility and achieve returns[4][53] - **Model Construction Process**: - **Core Layer**: Primarily consists of interest rate bonds, supplemented by credit bonds[53] - **Satellite Layer**: Includes high-volatility assets such as equities, overseas assets, and commodities. These assets are allocated across regions and strategies to reduce portfolio drawdowns and achieve stable returns[53] - **Model Evaluation**: The dual-layer structure effectively reduces portfolio volatility while maintaining stable returns, aligning with the fund's conservative investment objectives[4][53] 2. Risk Control System - **Model Construction Idea**: The primary goal is to limit maximum drawdowns to ensure principal safety while pursuing stable annualized returns[54] - **Model Construction Process**: - Strict risk control measures are implemented to ensure a positive return experience for investors at any entry point[54] - Risk budgets are adjusted dynamically to reduce exposure to asset classes with anticipated risks, avoiding "buying the dip" strategies[54] - **Model Evaluation**: The risk control system ensures a smooth investment experience, reducing irrational redemptions and maintaining portfolio management continuity[54] 3. Return Realization Path - **Model Construction Idea**: The model emphasizes a diversified approach to achieve returns through bonds, equities, and commodities[57] - **Model Construction Process**: - **Bond Investments**: Focus on government bonds, supplemented by credit bonds[57] - **Equity Investments**: Core allocation to passive funds, with at least 50% of total equity exposure. The remaining allocation is split between individual stocks and active funds, with intra-day stop-loss and stop-gain mechanisms[57] - **Commodity Strategy**: Utilized as a supplementary return source[57] - **Model Evaluation**: The diversified approach ensures stable returns while mitigating risks through dynamic adjustments and sector/region rotation[57] --- Model Backtesting Results 1. "Core + Satellite" Dual-Layer Framework - **Annualized Return**: 5.16% (A-class), 5.84% (Y-class)[24][28][32] - **Annualized Volatility**: 1.68% (A-class), 1.90% (Y-class)[24][28][32] - **Sharpe Ratio (IR)**: 2.61 (A-class), 2.23 (Y-class)[24][28][32] - **Maximum Drawdown**: -0.88% (both A-class and Y-class)[24][28][32] - **Calmar Ratio**: 5.66 (A-class), 6.33 (Y-class)[24][28][32] 2. Peer Comparison - **Annualized Return (Median)**: 4.76% (peer group)[49] - **Annualized Volatility (Median)**: 4.22% (peer group)[49] - **Sharpe Ratio (Median)**: 0.82 (peer group)[49] - **Maximum Drawdown (Median)**: -3.17% (peer group)[49] - **Calmar Ratio (Median)**: 1.53 (peer group)[49] 3. Performance Rankings - **Sharpe Ratio Ranking**: Top 1.20% among peers[49] - **Maximum Drawdown Ranking**: Top 2.40% among peers[49] - **Calmar Ratio Ranking**: Top 2.20% among peers[49] 4. Additional Metrics - **3-Month Positive Return Probability**: 100% for both A-class and Y-class[33] - **Longest Non-New High Period**: 42 days (A-class), 39 days (Y-class)[40][43] --- Quantitative Factors and Construction Methods 1. Factor Name: Multi-Asset Allocation - **Factor Construction Idea**: Diversify across asset classes to reduce correlation and smooth portfolio volatility[53] - **Factor Construction Process**: - Allocate to low-correlation assets such as bonds, equities, and commodities[53] - Adjust allocations dynamically based on market conditions and risk assessments[54] - **Factor Evaluation**: The multi-asset allocation strategy effectively balances risk and return, ensuring stable performance across market cycles[53][54] --- Factor Backtesting Results 1. Multi-Asset Allocation Factor - **Annualized Return**: 5.16% (A-class), 5.84% (Y-class)[24][28][32] - **Annualized Volatility**: 1.68% (A-class), 1.90% (Y-class)[24][28][32] - **Sharpe Ratio (IR)**: 2.61 (A-class), 2.23 (Y-class)[24][28][32] - **Maximum Drawdown**: -0.88% (both A-class and Y-class)[24][28][32] - **Calmar Ratio**: 5.66 (A-class), 6.33 (Y-class)[24][28][32]

AI 产业链公司业绩预告证实算力景气度 行 业 研 究 电子 2025 年 07 月 21 日 全球 AI 趋势明确，海外与国内有望共振 投资要点： 行 业 动 态 跟 踪 工业富联披露公告，预计 2025 上半年归母净利润 119.6—121.6 亿 元，同比增长 36.84%—39.12%；沪电股份预计 2025 上半年归母净利 润 16.5—17.5 亿元，同比增长 44.63%—53.40%；生益科技预计 2025 上半年归母净利润 14—14.5 亿元，同比增长 50%—56%；生益电子预 计 2025 上半年归母净利润 5.1—5.5 亿元，同比增长 432.01%— 471.45%。AI 算力产业链公司今年上半年业绩均实现较快增长，反映 出海外 AI 基建景气度依然较高。我们认为大模型的竞争与迭代仍在持 续，算力资本开支仍将维持较高强度。根据华尔街见闻，Meta 公司 CEO 扎克伯格表示，META 将投资数千亿美元建设数据中心，用于支持人 工智能发展。 大模型基座下的推理需求呈几十至百倍级增长 今年以来推理算力消耗呈倍数级增长，推理侧算力对训练侧算力 需求的承接推动总算力需求进一步增长。根据华 ...

Investment Rating - The industry rating is "Outperform the Market" [12] Core Viewpoints - The report highlights the long-term impact of hydropower on the grid, particularly focusing on GIL corridors, hydropower station automation, and external transmission channels [3] - The construction of the Yaxia hydropower project is expected to replicate the successful model of large-scale wind power bases in the northwest, with a target of over 120 million kilowatts of pumped storage capacity by 2030 [3] - The GIL corridor is anticipated to create significant investment opportunities, with an estimated investment of 300 billion for 2000 km of transmission lines [3] - Automation in hydropower stations is expected to enhance grid stability and efficiency, benefiting companies that provide control and monitoring equipment [3][4] - The planning capacity of the Motuo hydropower station is projected to exceed 70 GW, with a focus on supporting external transmission channels [4] Summary by Sections Industry Dynamics - The report discusses the recent initiation of the Yaxia hydropower project and its implications for the southwestern clean energy base construction [3] - It emphasizes the expected growth in the GIL corridor and the automation of hydropower stations, which will drive demand for related equipment [3][4] Investment Recommendations - The report suggests focusing on companies involved in GIL corridors, such as Pinggao Electric, China West Electric, and Changgao Electric, as well as those in hydropower station automation like Guodian NARI and Huazi Technology [5]

Group 1 - The current price recovery in China may reshape the global demand cycle, output cycle, profit distribution, and capital flow [2][12] - The global advantage of China's output system is reflected in asset pricing, leading to a systematic PB (Price-to-Book) adjustment, with Chinese assets expected to rise rapidly and the RMB (Renminbi) likely to appreciate [2][12] - Focus is on non-bank financials, low PB stocks, Hang Seng Technology, and military industry, while paying attention to long-term bonds and micro-market risks [3][12] Group 2 - In June, China's exports showed strong growth, with a year-on-year increase of 5.9%, improving from 4.7% previously, and exports to the US saw a significant month-on-month increase of 32.44% [11][12] - The report indicates a broad recovery in commodity prices in China, suggesting a potential restructuring of globalization, moving away from the previous US-dominated profit monopoly [12] - The Hong Kong stock market saw significant gains, with the Hang Seng Index rising by 2.84% and the Hang Seng Technology Index increasing by 5.53% [13][15] Group 3 - The A-share market experienced a broad rally, with the Shanghai Composite Index rising by 0.69% and the ChiNext Index leading the gains [19][31] - The healthcare sector outperformed, with significant gains in cancer treatment concepts and biopharmaceuticals [18][31] - High-end manufacturing sectors showed strong relative performance, while financial and real estate sectors faced declines [31][32] Group 4 - The report highlights a divergence in foreign capital index futures positions, with IC turning into a net short position and IF expanding its net short position, while IH remained stable [41][42] - The onshore and offshore RMB swap yields have declined, with the 10-year US Treasury yield surpassing the yields of Chinese bonds and swaps [45][46] Group 5 - Upcoming key focus includes the US M2 money supply and new home sales data [47][49]

行 业 汽车 2025 年 07 月 20 日 研 究 行 业 定 期 汽车 低空行业周报（7 月第 3 周）：国际低空经济博 览会将于下周召开，关注展会动态与产业进展 投资要点： 本周行情回顾 本周（7 月 14 日-7 月 18 日）Wind 低空经济指数上涨 2.69%，概 念板块排名 77/330，整体跑赢大盘（上证指数本周下跌 1.63%）。与 其他科技条线主题板块相比，跑输人形机器人指数 2.90pct，跑输 AI 算力指数 2.98pct。 报 告 本周 A 股及港股核心标的中，涨幅前五为：应流股份（上涨 20.37%），华依科技（上涨 18.60%），长源东谷（上涨 8.60%），航 天南湖（上涨 8.15%），绿能慧充（上涨 7.89%）；跌幅前五为：新晨 科技（下跌 7.68%），祥源文旅（下跌 3.48%），西域旅游（下跌 2.07%）， 雷科防务（下跌 1.40%），凯众股份（下跌 0.65%）。 美股整机标的中，Joby Aviation 上涨 47.67%；Archer Aviation 上涨 26.45%；Vertical Aerospace 上涨 41.96%；Eve Hold ...

Investment Rating - The report maintains an "Outperform" rating for the industry [5] Core Insights - The report highlights the acceleration of pilot lines for solid-state batteries both domestically and internationally, with equipment deliveries expected to peak soon. A significant order of $1 billion for eVTOLs utilizing solid-state batteries has been secured [2][9] - The photovoltaic sector is poised to benefit from a new round of growth stabilization policies from the Ministry of Industry and Information Technology, emphasizing structural adjustments and technological innovation [3][18] - The offshore wind sector is seeing positive developments with the UK easing entry barriers for offshore wind projects, which is expected to expedite project approvals [30][31] - The energy storage sector is witnessing the introduction of the first provincial capacity pricing policy in Gansu, clarifying the revenue model for independent storage [38][39] Summary by Sections 1. New Energy Vehicles and Lithium Battery Sector - The solid-state battery pilot lines are being rapidly constructed, with significant orders for eVTOLs [9][10] - Companies like Funeng Technology are set to launch advanced solid-state batteries by 2025, with a focus on high energy density [9][10] - Key companies to watch include CATL, Keda Technology, and others with competitive advantages in cost and technology [12] 2. New Energy Generation Sector 2.1 Photovoltaic Sector - The Ministry of Industry and Information Technology is implementing a new growth stabilization plan for key industries, including photovoltaics [18][19] - The report suggests that the photovoltaic industry should leverage policy opportunities to enhance competitiveness through innovation [19][20] - Investment recommendations include companies benefiting from supply-side reforms and those with strong demand growth [27][28] 2.2 Wind Power Sector - The UK has relaxed entry requirements for offshore wind projects, potentially increasing the number of projects eligible for funding [30][31] - The report highlights the progress of the Zhejiang deep-sea wind power base, which is expected to accelerate development [31][32] - Companies in the wind power supply chain are recommended for investment based on their growth potential [35] 3. Energy Storage Sector - Gansu Province has introduced a capacity pricing policy, which is expected to clarify revenue models for energy storage [38][39] - The Qinghai green electricity direct connection plan aims to optimize energy usage and enhance system flexibility [40][41] - Investment opportunities include companies involved in energy storage integration and those benefiting from the growth of the energy storage market [44] 4. Power Equipment Sector - The State Grid has announced the results of its third batch of ultra-high voltage equipment tenders, indicating ongoing investment in power infrastructure [47][48] - The Ministry of Industry and Information Technology is set to release growth stabilization plans for the power equipment sector, focusing on digital transformation [48][49] - Companies with overseas expansion capabilities and those involved in digital power solutions are highlighted as investment opportunities [49][52] 5. Industrial Control and Robotics Sector - The industrial sector is showing signs of recovery, with significant acquisitions and advancements in robotics technology [55][56] - The introduction of autonomous battery-swapping humanoid robots represents a significant innovation in the sector [57] - Investment recommendations focus on companies leading in automation and robotics technology [58][60] 6. Hydrogen Energy Sector - The report emphasizes the need to accelerate hydrogen energy applications in traditional industries, with a focus on green transformation [63] - The establishment of zero-carbon parks in Shandong is part of the broader strategy to promote hydrogen energy [64] - Companies involved in hydrogen production and fuel cell technology are recommended for investment [65]